Aflibercept-Based and Bevacizumab-Based Second Line Regimens in Patients with Metastatic Colorectal Cancer: Propensity Score Weighted-Analysis from a Multicenter Cohort.
Lucchetti J, Angotti L, Parisi A, Basso M, Polito MG, Zoratto F, Di Giacomo E, Nitti D, Minelli A, Salvatore L, Calegari MA, Lo Prinzi F, Gemma D, Signorelli C, Veroli M, Anghelone A, Galbato Muscio L, Di Cocco B, Trombetta G, Morelli C, Schietroma F, Vincenzi B, Cortellini A, Tonini G.
Lucchetti J, et al. Among authors: trombetta g.
Clin Colorectal Cancer. 2025 Jan 2:S1533-0028(24)00121-X. doi: 10.1016/j.clcc.2024.12.007. Online ahead of print.
Clin Colorectal Cancer. 2025.
PMID: 39856001